{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:34:23Z","timestamp":1789565663708,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.vaccine.2018.02.059","type":"journal-article","created":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T20:55:56Z","timestamp":1519332956000},"page":"1711-1719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data"],"prefix":"10.1016","volume":"36","author":[{"given":"Mohammadreza","family":"Shaghaghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Soleyman-jahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Abolhassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Yazdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed-Ridha","family":"Barbouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"McKinlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asghar","family":"Aghamohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.02.059_b0005","doi-asserted-by":"crossref","first-page":"470","DOI":"10.15585\/mmwr.mm6518a4","article-title":"Progress toward polio eradication \u2013 worldwide, 2015\u20132016","volume":"65","author":"Morales","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2018.02.059_b0010","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2018.02.059_b0015","unstructured":"Global Polio Eradication Initiative. Polio now, http:\/\/polioeradication.org\/polio-today\/polio-now [accessed 3 January 2017]."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2018.02.059_b0020","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1093\/infdis\/175.Supplement_1.S176","article-title":"Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature","volume":"175","author":"Alexander","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.059_b0025","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1086\/379791","article-title":"Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis","volume":"188","author":"Khetsuriani","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.059_b0030","series-title":"Vaccines","first-page":"598","article-title":"Poliovirus vaccine-live","author":"Sutter","year":"2013"},{"key":"10.1016\/j.vaccine.2018.02.059_b0035","series-title":"Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality","author":"Stratton","year":"1994"},{"key":"10.1016\/j.vaccine.2018.02.059_b0040","unstructured":"CDC. Update on vaccine-derived polioviruses\u2013worldwide, April 2011-June 2012. MMWR Morb Mortal Wkly Rep 2012; 61: p. 741\u20136."},{"key":"10.1016\/j.vaccine.2018.02.059_b0045","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3201\/eid2210.151071","article-title":"Vaccine-derived polioviruses and children with primary immunodeficiency, Iran, 1995\u20132014","volume":"22","author":"Shaghaghi","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.059_b0050","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.vaccine.2015.01.018","article-title":"Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication","volume":"33","author":"Guo","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.059_b0055","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3389\/fimmu.2017.01103","article-title":"Prolonged excretion of poliovirus among individuals with primary immunodeficiency disorder: an analysis of the world health organization registry","volume":"8","author":"Macklin","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2018.02.059_b0060","unstructured":"World Health Organization\/United Nations Children's Fund. WHO\/UNICEF estimates of national immunization coverage, http:\/\/www.who.int\/immunization\/monitoring_surveillance\/routine\/coverage\/en\/index4.html [accessed 20 November 2016]."},{"key":"10.1016\/j.vaccine.2018.02.059_b0065","unstructured":"The World Bank. World Bank GNI per capita Operational Guidelines & Analytical Classifications, https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups [accessed 20 November 2016]."},{"key":"10.1016\/j.vaccine.2018.02.059_b0070","doi-asserted-by":"crossref","first-page":"763","DOI":"10.15585\/mmwr.mm6530a3","article-title":"Update on vaccine-derived polioviruses - worldwide, January 2015-May 2016","volume":"65","author":"Jorba","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2018.02.059_b0075","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10875-015-0198-5","article-title":"The 2015 IUIS phenotypic classification for primary immunodeficiencies","volume":"35","author":"Bousfiha","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.vaccine.2018.02.059_b0080","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1099\/vir.0.18974-0","article-title":"Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis","volume":"84","author":"Buttinelli","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.02.059_b0085","unstructured":"CDC. Laboratory surveillance for wild and vaccine-derived polioviruses\u2013worldwide, January 2007-June 2008. MMWR Morb Mortal Wkly Rep 2008; 57: p. 967\u201370."},{"key":"10.1016\/j.vaccine.2018.02.059_b0090","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1128\/JVI.02122-08","article-title":"Evolution of the sabin vaccine into pathogenic derivatives without appreciable changes in antigenic properties: need for improvement of current poliovirus surveillance","volume":"83","author":"Yakovenko","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.02.059_b0095","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3201\/eid1607.091606","article-title":"Vaccine-associated paralytic poliomyelitis in immunodeficient children, Iran, 1995\u20132008","volume":"16","author":"Shahmahmoodi","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.059_b0100","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1128\/CVI.00293-12","article-title":"High susceptibility for enterovirus infection and virus excretion features in Tunisian patients with primary immunodeficiencies","volume":"19","author":"Driss","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.02.059_b0105","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1587-y","article-title":"Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis","volume":"16","author":"Foiadelli","year":"2016","journal-title":"Bmc Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.059_b0110","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3201\/eid1806.120037","article-title":"Immunodeficiency-associated vaccine-derived poliovirus type 3 in infant, South Africa, 2011","volume":"18","author":"Gumede","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.059_b0115","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1056\/NEJMoa1008677","article-title":"Vaccine-derived poliomyelitis 12\u202fyears after infection in Minnesota","volume":"364","author":"DeVries","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.02.059_b0120","doi-asserted-by":"crossref","first-page":"12623","DOI":"10.1128\/JVI.79.20.12623-12634.2005","article-title":"Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient","volume":"79","author":"Yang","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.02.059_b0125","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1128\/JCM.36.10.2893-2899.1998","article-title":"Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient","volume":"36","author":"Kew","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.02.059_b0130","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1086\/596052","article-title":"Transmission of imported vaccine-derived poliovirus in an undervaccinated community in Minnesota","volume":"199","author":"Alexander","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.059_b0135","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/01.inf.0000069792.60744.5b","article-title":"Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child","volume":"22","author":"Hidalgo","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.02.059_b0140","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMc1508104","article-title":"Two cases of vaccine-derived poliovirus infection in an oncology ward","volume":"374","author":"Schubert","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.02.059_b0145","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.1016\/j.vaccine.2012.10.035","article-title":"Prevalence of prolonged and chronic poliovirus excretion among persons with primary immune deficiency disorders in Sri Lanka","volume":"30","author":"de Silva","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.059_b0150","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3201\/eid1411.080517","article-title":"Paralysis case and contact spread of recombinant vaccine-derived poliovirus, Spain","volume":"14","author":"Avell\u00f3n","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.059_b0155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.biologicals.2006.02.005","article-title":"Vaccine-derived poliovirus from long term excretors and the end game of polio eradication","volume":"34","author":"Mart\u00edn","year":"2006","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2018.02.059_b0160","doi-asserted-by":"crossref","first-page":"9179","DOI":"10.1128\/JVI.00468-08","article-title":"Changes in population dynamics during long-term evolution of sabin type 1 poliovirus in an immunodeficient patient","volume":"82","author":"Odoom","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.02.059_b0165","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1128\/JVI.74.16.7381-7390.2000","article-title":"Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model","volume":"74","author":"Gavrilin","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.02.059_b0170","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1539-6924.2006.00827.x","article-title":"Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication","volume":"26","author":"Tebbens","year":"2006","journal-title":"Risk Anal"},{"key":"10.1016\/j.vaccine.2018.02.059_b0175","doi-asserted-by":"crossref","unstructured":"Dunn G, Klapsa D, Wilton T, Stone L, Minor PD, Martin J. Twenty-eight years of poliovirus replication in an immunodeficient individual: impact on the global polio eradication initiative. PLoS Pathog 2015; 11.","DOI":"10.1371\/journal.ppat.1005114"},{"key":"10.1016\/j.vaccine.2018.02.059_b0180","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/viro.1999.0003","article-title":"Evolution of poliovirus type 1 during 5.5 years of prolonged enteral replication in an immunodeficient patient","volume":"265","author":"Bellmunt","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.02.059_b0185","first-page":"347","article-title":"Stopping poliovirus vaccination after eradication: issues and challenges","volume":"78","author":"Wood","year":"2000","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2018.02.059_b0190","first-page":"741","article-title":"Update on vaccine-derived polioviruses\u2013worldwide, April 2011-June 2012","volume":"61","author":"Centers for Disease C, Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2018.02.059_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00685","article-title":"Patients with primary immunodeficiencies are a reservoir of Poliovirus and a risk to Polio eradication","volume":"8","author":"Aghamohammadi","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2018.02.059_b0200","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.3201\/eid2310.170724","article-title":"Poliovirus excretion in children with primary immunodeficiency disorders, India","volume":"23","author":"Madhu Chhanda","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.059_b0205","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0897.2006.00409.x","article-title":"Consanguinity in primary immunodeficiency disorders; the report from Iranian Primary Immunodeficiency Registry","volume":"56","author":"Rezaei","year":"2006","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.vaccine.2018.02.059_b0210","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s10875-014-0001-z","article-title":"Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry","volume":"34","author":"Aghamohammadi","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.vaccine.2018.02.059_b0215","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.2011.06260.x","article-title":"Primary immunodeficiencies in highly consanguineous North African populations","volume":"1238","author":"Barbouche","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2018.02.059_b0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/2249-4863.109934","article-title":"Systematic reviews and meta-analysis: understanding the best evidence in primary healthcare","volume":"2","author":"Gopalakrishnan","year":"2013","journal-title":"J Family Med Prim Care"},{"key":"10.1016\/j.vaccine.2018.02.059_b0225","doi-asserted-by":"crossref","first-page":"h1088","DOI":"10.1136\/bmj.h1088","article-title":"Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study","volume":"350","author":"Vale","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2018.02.059_b0230","doi-asserted-by":"crossref","first-page":"e0122316","DOI":"10.1371\/journal.pone.0122316","article-title":"Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis","volume":"10","author":"Soleyman-Jahi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.02.059_b0235","doi-asserted-by":"crossref","unstructured":"Gromeier M, Nomoto A. Determinants of poliovirus pathogenesis. In: Semler BL, Wimmer E, editors. Molecular biology of picornaviruses. Washington, DC 2002: ASM Press. p. 367\u201379.","DOI":"10.1128\/9781555817916.ch29"},{"key":"10.1016\/j.vaccine.2018.02.059_b0240","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1128\/JCM.01122-14","article-title":"Sequential asymptomatic enterovirus infections in a patient with major histocompatibility complex class II primary immunodeficiency","volume":"52","author":"Driss","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.02.059_b0245","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0022-3476(74)80667-0","article-title":"Nonparalytic poliovirus infections in patients with severe combined immunodeficiency disease","volume":"84","author":"Lopez","year":"1974","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2018.02.059_b0250","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","article-title":"Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency 2015","volume":"35","author":"Picard","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.vaccine.2018.02.059_b0255","doi-asserted-by":"crossref","first-page":"e1002393","DOI":"10.1371\/journal.ppat.1002393","article-title":"Neurons are MHC class I-dependent targets for CD8 T cells upon neurotropic viral infection","volume":"7","author":"Chevalier","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2018.02.059_b0260","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fneur.2015.00163","article-title":"CD8(+) T cell-mediated neuronal dysfunction and degeneration in limbic encephalitis","volume":"6","author":"Ehling","year":"2015","journal-title":"Front Neurol"},{"key":"10.1016\/j.vaccine.2018.02.059_b0265","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1096\/fj.09-136200","article-title":"CD8+ T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitability","volume":"23","author":"Melzer","year":"2009","journal-title":"Faseb J"},{"key":"10.1016\/j.vaccine.2018.02.059_b0270","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/08820139.2013.859156","article-title":"Combined immunodeficiency presenting with vaccine-associated paralytic poliomyelitis: a case report and narrative review of literature","volume":"43","author":"Shaghaghi","year":"2014","journal-title":"Immunol Invest"},{"key":"10.1016\/j.vaccine.2018.02.059_b0275","series-title":"Protides of the biological fluids, proceeding of the sisteenth colloquim","first-page":"315","article-title":"The biologic significance of IgA in mucous secretions: response to oral Polio vaccine in IgA deficient subjets","author":"South","year":"1969"},{"key":"10.1016\/j.vaccine.2018.02.059_b0280","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/sji.12040","article-title":"Frequency and expression of inhibitory markers of CD4(+) CD25(+) FOXP3(+) regulatory T cells in patients with common variable immunodeficiency","volume":"77","author":"Arandi","year":"2013","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2018.02.059_b0285","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cellimm.2013.03.003","article-title":"Evaluation of CD4+CD25+FOXP3+ regulatory T cells function in patients with common variable immunodeficiency","volume":"281","author":"Arandi","year":"2013","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2018.02.059_b0290","doi-asserted-by":"crossref","first-page":"233","DOI":"10.18176\/jiaci.0069","article-title":"T-cell abnormalities in common variable immunodeficiency","volume":"26","author":"Azizi","year":"2016","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.vaccine.2018.02.059_b0295","first-page":"335","article-title":"Antiviral activity of pocapavir in a randomized, blinded, placebo-controlled human oral poliovirus vaccine challenge model","volume":"215","author":"Collett","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.059_b0300","unstructured":"WHO. Expanding contributions of the global laboratory network for poliomyelitis eradication, 2000-2001. Wkly Epidemiol Rec 2002; 77: p. 133\u20137."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:25:07Z","timestamp":1759400707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18302469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":60,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0264410X18302469"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}